![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
Prévisions du marché de l’immunohistochimie en Amérique du Sud jusqu’en 2028 – Impact du COVID-19 et analyse régionale par application (diagnostics et tests de médicaments), produit (anticorps, équipement, réactifs et kits) et utilisateur final (hôpitaux et laboratoires de diagnostic, instituts de recherche et autres )
Introduction au marché
Les principaux pays inclus dans le cadre de l\'analyse de SAM comprennent l\'Argentine, le Brésil et le reste de SAM. Le Brésil a dominé le marché en 2021. Le Brésil est la plus grande économie d\'Amérique latine et son secteur de la santé est réparti entre des acteurs publics et privés. La fabrication locale se limite aux consommables et aux articles ordinaires, et il existe peu de fabricants d\'appareils de haute technologie. C’est pourquoi le Brésil importe de nombreux dispositifs médicaux d’autres pays. Le cancer est l’une des principales maladies épidémiques et le nombre de personnes diagnostiquées avec un cancer a doublé au cours des trois dernières décennies. Selon les données présentées dans un article Revista Brasileira de Cancerologia 2018, entre 2018 et 2019, il y aurait environ 600 000 nouveaux cas de cancer dans le pays. Selon le rapport de VanEck Research publié en 2017, le marché du diagnostic au Brésil est en croissance. Il existe environ 22 000 laboratoires répartis dans tout le Brésil. Les quatre principaux acteurs du marché sont les quatre principaux acteurs du marché : Diagnósticos da América SA (DASA), Fleury SA, Centro de Imagem Diagnósticos SA (Alliar) et Instituto Hermes Pardini SA (Hermes Pardini). Le facteur clé de la croissance du marché du diagnostic est le vieillissement de la population. Le rapport mentionne également que 52 % de la population totale aura 45 ans ou plus d\'ici 2050. Sur la base des facteurs mentionnés ci-dessus, le Brésil est susceptible de présenter diverses opportunités de croissance pour les acteurs du marché de l\'immunohistochimie au cours de la période de prévision.
Les pays de la SAM, en particulier le Brésil, sont fortement touchés par l\'épidémie de COVID-19. L’épidémie a gravement affecté les services médicaux de la région. En outre, les pays sont célèbres pour le tourisme médical, qui est également influencé par la pandémie. Le Brésil, l’Argentine, l’Uruguay, le Chili, le Pérou et la Colombie sont touchés par la deuxième vague de l’épidémie de COVID-19. Selon Worldometer, au 3 septembre 2021, le Brésil avait signalé 558 597 victimes et 21 millions de nouveaux cas de COVID-19. Il y a eu 5,2 millions de nouveaux cas en Argentine, signe de la deuxième vague d’épidémie de COVID-19. Il est prévu que SAM impose un deuxième confinement, ce qui finira par entraver le secteur de la santé dans la région. Le Brésil, l\'Argentine, l\'Uruguay, le Chili, le Pérou et la Colombie sont concernés par la deuxième vague. Parmi eux, le Brésil a enregistré la majorité des décès.
Aperçu et dynamique du marché
Le marché de l\'immunohistochimie SAM devrait passer de 129,48 millions de dollars US en 2021 à 202,68 millions de dollars US d\'ici 2028 ; on estime qu\'il augmentera à un TCAC de 6,6 % de 2021 à 2028. L\'immunohistochimie (IHC) fait référence à une application importante des anticorps monoclonaux et polyclonaux pour la détermination tissulaire et la distribution d\'antigènes d\'une maladie particulière. Il est principalement utilisé pour détecter plusieurs maladies infectieuses comme la dengue, l\'hépatite et le virus de l\'immunodéficience humaine (VIH). Les maladies chroniques telles que l’obésité, le cancer, le diabète, les maladies cardiaques et les accidents vasculaires cérébraux sont également considérées comme les principales applications majeures de l’immunohistochimie qui facilitent le diagnostic de ces maladies. Le diabète prévaut à un taux élevé dans la population gériatrique de la région. La prévalence du diabète touche davantage les personnes en surpoids et obèses. Les taux d’obésité ont augmenté rapidement dans les économies développées et en développement de la région. Des facteurs tels qu’un mode de vie malsain et la vie sédentaire sont parmi les principaux responsables de l’augmentation du nombre de personnes obèses. Les maladies cardiovasculaires (MCV) comprennent les maladies cérébrovasculaires, les cardiopathies rhumatismales, les maladies coronariennes et d\'autres affections. C’est la cause la plus importante de morbidité et de mortalité dans la région. En outre, l’incidence du cancer et les taux de mortalité ont augmenté dans toute la région, faisant du cancer la principale cause de décès. Une telle augmentation de l\'incidence des maladies chroniques et infectieuses devrait créer une demande de tests d\'immunoessai dans la région SAM.
Segments clés du marché
En termes de produit, le segment des anticorps représentait la plus grande part du marché de l’immunohistochimie SAM en 2020. En termes d’application, le segment des diagnostics détenait une part de marché plus importante du marché de l’immunohistochimie SAM en 2020. De plus, le segment des hôpitaux et des laboratoires de diagnostic détenait une part plus importante du marché de l\'immunohistochimie SAM en fonction de l\'utilisateur final en 2020.
Principales sources et sociétés répertoriées
Quelques sources primaires et secondaires majeures mentionnées pour la préparation de ce rapport sur le marché de l\'immunohistochimie SAM sont les sites Web des entreprises, les rapports annuels, les rapports financiers, les documents du gouvernement national et les bases de données statistiques, entre autres. Les principales sociétés répertoriées dans le rapport sont Abcam plc ; Agilent Technologies, Inc. ; Bio SB ; LABORATOIRES BIO-RAD INC.; Danaher ; F. HOFFMANN-LA ROCHE LTÉE; MERCK KGaA ; PerkinElmer Inc. ; et THERMO FISHER SCIENTIFIC INC.
Rapport sur les raisons d\'acheter
< ul>Segmentation du marché de l\'immunohistochimie SAM
Marché de l\'immunohistochimie SAM - Par produit
- Équipement
- Systèmes de coloration de lames
- Systèmes de microréseaux de tissus
- Traitement des tissus Systèmes
- Scanners de lames
- Autres équipements
- Anticorps
- Anticorps primaires
- Anticorps secondaires
- Réactifs
- Colorations histologiques
- Réactifs de blocage et de fixation
- Substrats chromogènes
- Réactifs de fixation
- Stabilisants
- Solvants organiques
- Enzymes protéolytiques
- Diluants
- Kits
Marché de l\'immunohistochimie SAM - Par application
- Diagnostic
- Cancer
- Maladies infectieuses
- Maladies auto-immunes
- Diabète sucré
- Maladies néphrologiques
- Autres
- Dépistage de médicaments
Marché de l\'immunohistochimie SAM - Par utilisateur final
- Hôpitaux et laboratoires de diagnostic
- Instituts de recherche
- Autres
Marché de l\'immunohistochimie SAM - Par pays
- Brésil
- Argentine
- Reste de SAM
Marché de l\'immunohistochimie SAM - Profils d\'entreprises
- Abcam plc
- Agilent Technologies, Inc.
- Bio SB
- LABORATOIRES BIO-RAD INC.
- Danaher
- F. HOFFMANN-LA ROCHE LTD.
- MERCK KGaA
- PerkinElmer Inc.
- THERMO FISHER SCIENTIFIC INC.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 SAM Immunohistochemistry Market – By Product
1.3.2 SAM Immunohistochemistry Market – By Application
1.3.3 SAM Immunohistochemistry Market – By End User
1.3.4 SAM Immunohistochemistry Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SAM Immunohistochemistry Market – Market Landscape
4.1 Overview
4.2 SAM PEST Analysis
4.3 Experts Opinion
5. SAM Immunohistochemistry Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidences of Chronic and Infectious Diseases
5.1.2 Increasing R&D Investments by Biotechnology & Biopharmaceutical Companies
5.2 Key Market Restraints
5.2.1 Limitations Associated with Immunohistochemistry
5.3 Key Market Opportunities
5.3.1 Development Opportunities in Emerging Countries
5.4 Future Trends
5.4.1 Increasing Acceptance of Automation in Immunohistochemistry
5.5 Impact Analysis
6. Immunohistochemistry Market – SAM Analysis
6.1 SAM Immunohistochemistry Market Revenue Forecast and Analysis
7. SAM Immunohistochemistry Market Analysis– By Product
7.1 Overview
7.2 SAM Immunohistochemistry Market, By Product 2021 & 2028 (%)
7.3 Antibodies
7.3.1 Overview
7.3.2 Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.3 Primary Antibodies
7.3.3.1 Overview
7.3.3.2 Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.4 Secondary Antibodies
7.3.4.1 Overview
7.3.4.2 Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Equipment Market
7.4.1 Overview
7.4.2 Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.3 Slide Staining Systems
7.4.3.1 Overview
7.4.3.2 Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.4 Tissue Microarrays
7.4.4.1 Overview
7.4.4.2 Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.5 Tissue Processing Systems
7.4.5.1 Overview
7.4.5.2 Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.6 Slide Scanners
7.4.6.1 Overview
7.4.6.2 Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.7 Other Equipments
7.4.7.1 Overview
7.4.7.2 Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5 Reagents Market
7.5.1 Overview
7.5.2 Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.3 Histological Stains
7.5.3.1 Overview
7.5.3.2 Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.4 Blocking Sera & Reagents Market
7.5.4.1 Overview
7.5.4.2 Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.5 Chromogenic Substrates Market
7.5.5.1 Overview
7.5.5.2 Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.6 Stabilizers
7.5.6.1 Overview
7.5.6.2 Stabilizers Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.7 Proteolytic Enzymes
7.5.7.1 Overview
7.5.7.2 Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.8 Organic Solvents
7.5.8.1 Overview
7.5.8.2 Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.9 Fixation Reagents
7.5.9.1 Overview
7.5.9.2 Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.10 Diluents
7.5.10.1 Overview
7.5.10.2 Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.6 Kits Market
7.6.1 Overview
7.6.2 Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
8. SAM Immunohistochemistry Market Analysis – By Application
8.1 Overview
8.2 SAM Immunohistochemistry Market Share by Application 2021 & 2028 (%)
8.3 Diagnostics
8.3.1 Overview
8.3.2 Diagnostics Market Revenue and Forecast to 2028 (US$ Mn)
8.3.3 Cancer
8.3.3.1 Overview
8.3.3.2 Cancer Market Revenue and Forecast to 2028 (US$ Mn)
8.3.4 Infectious Diseases
8.3.4.1 Overview
8.3.4.2 Infectious Diseases Market Revenue and Forecast to 2028 (US$ Mn)
8.3.5 Autoimmune Diseases
8.3.5.1 Overview
8.3.5.2 Autoimmune Diseases Market Revenue and Forecast to 2028 (US$ Mn)
8.3.6 Diabetes Mellitus
8.3.6.1 Overview
8.3.6.2 Diabetes Mellitus Market Revenue and Forecast to 2028 (US$ Mn)
8.3.7 Nephrological Diseases
8.3.7.1 Overview
8.3.7.2 Nephrological Diseases Market Revenue and Forecast to 2028 (US$ Mn)
8.3.8 Others
8.3.8.1 Overview
8.3.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Drug Testing
8.4.1 Overview
8.4.2 Drug Testing Market Revenue and Forecast to 2028 (US$ Mn)
9. SAM Immunohistochemistry Market Analysis– By End User
9.1 Overview
9.2 SAM Immunohistochemistry Market, By End User 2021 & 2028 (%)
9.3 Hospital & Diagnostic Laboratories
9.3.1 Overview
9.3.2 Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
9.4 Research Institutes
9.4.1 Overview
9.4.2 Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
9.5 Others
9.5.1 Overview
9.5.2 Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10. SAM Immunohistochemistry Market – Country Analysis
10.1 SAM Immunohistochemistry Market Revenue and Forecasts To 2028
10.1.1 SAM Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)
10.1.1.1 Argentina Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.1.1 Argentina Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.1.2 Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.1.1.1.2.1 Argentina Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)
10.1.1.1.2.2 Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.1.1.1.2.3 Argentina Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)
10.1.1.1.3 Argentina Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)
10.1.1.1.3.1 Argentina Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)
10.1.1.1.4 Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.1.1.2 Brazil Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.2.1 Brazil Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.2.2 Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.1.1.2.2.1 Brazil Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)
10.1.1.2.2.2 Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.1.1.2.2.3 Brazil Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)
10.1.1.2.3 Brazil Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)
10.1.1.2.3.1 Brazil Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)
10.1.1.2.4 Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.1.1.3 Rest of SAM: Immunohistochemistry Market– Revenue and Forecast to 2028 (USD Mn)
10.1.1.3.1 Rest of SAM: Immunohistochemistry Market– Revenue and Forecast to 2028 (USD Mn)
10.1.1.3.2 Rest of SAM Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.1.1.3.2.1 Rest of SAM Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)
10.1.1.3.2.2 Rest of SAM Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.1.1.3.2.3 Rest of SAM Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)
10.1.1.3.3 Rest of SAM Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)
10.1.1.3.3.1 Rest of SAM Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)
10.1.1.3.4 Rest of SAM Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
11. Impact Of COVID-19 Pandemic on SAM Immunohistochemistry Market
11.1 SAM: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic developments
12.3.1 Overview
13. Company Profiles
13.1 F. HOFFMANN-LA ROCHE LTD.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 MERCK KGaA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 PerkinElmer Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 THERMO FISHER SCIENTIFIC INC.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Abcam plc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Agilent Technologies, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 BIO-RAD LABORATORIES INC.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Danaher
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Bio SB
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. SAM Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)
Table 2. Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 3. Argentina Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 4. Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 5. Argentina Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 6. Argentina Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 7. Argentina Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
Table 8. Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 9. Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 10. Brazil Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 11. Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 12. Brazil Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 13. Brazil Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 14. Brazil Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
Table 15. Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 16. Rest of SAM Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 17. Rest of SAM Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 18. Rest of SAM Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 19. Rest of SAM Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 20. Rest of SAM Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 21. Rest of SAM Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
Table 22. Rest of SAM Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 23. Organic Developments Done By Companies
Table 24. Inorganic developments done by Companies
Table 25. Glossary of Terms
LIST OF FIGURES
Figure 1. SAM Immunohistochemistry Market Segmentation
Figure 2. SAM Immunohistochemistry Market Segmentation, By Country
Figure 3. SAM Immunohistochemistry Market Overview
Figure 4. Antibodies Segment Held the Largest Share of the Market in 2021
Figure 5. Brazil to Show Significant Growth During Forecast Period
Figure 6. SAM PEST Analysis
Figure 7. Impact Analysis of Drivers and Restraints Pertaining to SAM Immunohistochemistry Market
Figure 8. SAM Immunohistochemistry Market – Revenue Forecast and Analysis
Figure 9. SAM Immunohistochemistry Market, by Product 2021 & 2028 (%)
Figure 10. SAM Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. SAM Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. SAM Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. SAM Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. SAM Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. SAM Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 16. SAM Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. SAM Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. SAM Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 19. SAM Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. SAM Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. SAM Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. SAM Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. SAM Stabilizer: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. SAM Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. SAM Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. SAM Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 27. SAM Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 28. SAM Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 29. SAM Immunohistochemistry Market Share by Application 2021 & 2028 (%)
Figure 30. SAM Diagnostics Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 31. SAM Cancer Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 32. SAM Infectious Diseases Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 33. SAM Autoimmune Diseases Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 34. SAM Diabetes mellitus Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 35. SAM Nephrological Diseases Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 36. SAM Others Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 37. SAM Drug Testing Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 38. SAM Immunohistochemistry Market, by End User 2021 & 2028 (%)
Figure 39. SAM Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 40. SAM Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 41. SAM Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 42. SAM Immunohistochemistry Market Revenue Overview, by Country, 2021 (US$ Mn)
Figure 43. SAM Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)
Figure 44. Argentina Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 45. Brazil Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 46. Rest of SAM: Immunohistochemistry Market– Revenue and Forecast to 2028 (USD Mn)
Figure 47. Impact Of COVID-19 Pandemic in SAM Country Markets
- Abcam plc
- Agilent Technologies, Inc.
- Bio SB
- BIO-RAD LABORATORIES INC.
- Danaher
- F. HOFFMANN-LA ROCHE LTD.
- MERCK KGaA
- PerkinElmer Inc.
- THERMO FISHER SCIENTIFIC INC.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the SAM immunohistochemistry market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the SAM immunohistochemistry market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the immunohistochemistry market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution